Moonfare’s recent investment strategy opens a door to a key industry nowadays, expected to reach $727bn by 2025 – biotechnology. The fund manager holds…
Investors hunt for returns and find private equity. The asset class continues to outperform public markets. And individuals become an increasingly important source of…
Company grows investor base to over 1,000 through Covid-19 pandemic; investors increasingly allocate to multiple funds and build diversified private markets portfolios Exceptional track…
The latest addition to Moonfare’s platform includes a historically top-quartile strategy with a robust opportunity set, razor-sharp deal filter and, best of all, low…